Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.88 USD | +1.61% | +8.82% | -30.20% |
Apr. 29 | Canaccord Genuity Adjusts Price Target on Guardant Health to $30 From $45, Maintains Buy Rating | MT |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.20% | 2.3B | |
-16.10% | 11.41B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M | |
+15.53% | 227M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health Says FDA Advisory Panel Will Review Shield Blood Test for Colorectal Cancer Screening; Shares Rise